Multivalent medicines that
deliver transformative outcomes
At Arpelos, we’re engineering targeted therapeutics that achieve unprecedented potency and selectivity. We’re a dynamic, nimble team spanning compute, immunology, and protein engineering hailing from UCSF, Penn, Stanford, and MIT.
We’re a Seed-stage biotech company based in Kendall Square supported by top biotech investors. Our mission is to create multivalent medicines that deliver transformative outcomes.
© 2025 Arpelos Biosciences, Inc.
Multivalent medicines that deliver transformative outcomes
At Arpelos, we’re engineering targeted therapeutics that achieve unprecedented potency and selectivity. We’re a dynamic, nimble team spanning compute, immunology, and protein engineering hailing from UCSF, Penn, Stanford, and MIT.
We’re a Seed-stage biotech company based in Kendall Square supported by top biotech investors. Our mission is to create multivalent medicines that deliver transformative outcomes.
learn more
© 2025 Arpelos Biosciences, Inc.